While no companies went public this past week, the IPO market saw some activity as one company submitted an initial filing. With nearly all of the year’s SPACs trading below issue, Social Capital Hedosophia II (IPOB.U) and Social Capital Hedosophia III (IPOC.U) delayed thei
Loha, an organic food distributor in China, announced terms for its IPO on Friday. In its latest filing, the company also added Tiger Brokers, Valuable Capital, and Prime Number Capital as underwriters, and selected the Nasdaq as its listing exchange.
The Shenzhen, China-based co
Hitek Global, which provides IT consulting and solutions services in China, raised the proposed deal size for its upcoming US IPO on Thursday.
The Xiamen, China-based company now plans to raise $20 million at a market cap of $75 million by offering 4 million shares at a price ran
GAN Limited, an internet gambling software provider in the UK, filed on Wednesday with the SEC to raise up to $35 million in an initial public offering. The company is currently listed on London's AIM exchange under the symbol "GAN."
The London, United Kingdom-based company was f
While the coronavirus outbreak has put the global IPO market on ice, an Italian respirator mask maker is preparing to go public as global demand for its products soars. Rome-based GVS sells filtration products used for healthcare services, industrial equipment, automobiles, appli
The market's broad sell-off has even roiled blank check IPOs, whose only asset is the cash initial investors put in.
Blank check companies give investors the right to redeem their shares for $10 plus interest, either:
WiMi Hologram Cloud, a Chinese provider of ad services and software used in holographic augmented reality, lowered the proposed deal size for its upcoming IPO on Friday, March 20. In its latest filing, the company also removed Everbright Sun Hung Kai as an und
There are no IPOs scheduled for the week ahead as the IPO market shutdown continues. Two SPACs may price on a day-to-day basis.
Renaissance Capital will be releasing its 1Q20 Quarterly Reviews for both the US and the Global IPO markets. Our Quarterly Reviews provide an in-depth a
The IPO market showed little activity, with no launches or pricings. The silver lining for IPO investors is thatthe IPO market tends to outperform following a shutdown. A few filings are keeping IPO market alive, as a Chinese issuer, a biotech, and a SPAC submitted initial filing
In the first quarter of 2020, 24 IPOs raised $6.8 billion, up from the 1Q19 by deal count and proceeds. Activity waned in March as the stock market’s sharp sell-off closed the IPO window. Biotechs once again dominated issuance, as health care comprised half of all IPOs. Wit
In the first quarter of 2020, 24 IPOs raised $6.8 billion, mostly in the first two months before the market's downturn. Despite the IPO window slamming shut in March, activity increased from the prior year period, when 18 IPOs raised $4.7 billion. Health care was the most active
UTime, a Chinese mobile phone and electronics manufacturer, filed on Wednesday with the SEC to raise up to $22 million in an initial public offering. The company provides cost-effective mobile devices to emerging markets such as India, South Asia, and Africa.
The Shenzhen, China-
Sustainable Opportunities Acquisition, a blank check company targeting a environmentally sustainable industrial business, filed on Tuesday with the SEC to raise up to $300 million in an initial public offering.
The Dallas, TX-based company plans to raise $300 million by offering
The Renaissance International IPO Index (Ticker: IPOXUS), the underlying index for the Renaissance International IPO ETF (Ticker: IPOS), will implement the following constituent changes at the market's close on Friday, March 20, 2019:Additions:
Pharmaron Beijing
Poly Pr
The Renaissance IPO Index (Ticker: IPOUSA), the underlying index for the Renaissance IPO ETF (Ticker: IPO), will implement the following constituent changes at the market’s close on Friday, March 20, 2019:Additions:
OneConnect Financial Technology
PPD
Keros Therapeutics, a Phase 1 biotech developing treatments for hematological and musculoskeletal disorders, filed on Monday with the SEC to raise up to $86 million in an initial public offering.
The Lexington, MA-based company was founded in 2015 and booked $10 million in
Keros Therapeutics, a Phase 1/2 biotech developing treatments for hematological and musculoskeletal disorders, filed on Monday with the SEC to raise up to $86 million in an initial public offering.
The Lexington, MA-based company was founded in 2015 and booked $10 mill
Following the IPO Index’s sharpest drop ever recorded, one cannabis SPAC is keeping the IPO market alive, expected to raise $150 million in the week ahead. Social Capital’s latest SPACs (IPOB.U, IPOC.U) are also eligible to price this week.
Led by former Cano